Moreno, Angel Faeth T.
HRN: 26-44-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/18/2025
01/25/2025
IVT
50mg
Q24
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes